Leadership & Pay ·
Vertex Pharmaceuticals appointed Jonathan Poole as Executive Vice President and Chief Financial Officer, effective…
VRTXVertex Pharmaceuticals Inc / MA
Vertex Pharmaceuticals appointed Jonathan Poole as Executive Vice President and Chief Financial Officer, effective January 1, 2027. Charles F. Wagner, Jr., will cease serving as CFO but remain Executive Vice President and Chief Operating Officer. Mr. Poole’s employment agreement includes a $750,000 base salary and a target annual bonus of 90% of base salary. The company operates in the biotechnology industry, focusing on developing therapies for cystic fibrosis and other serious diseases.